Needles, Syringes, IV Access Market Research Reports & Industry Analysis
This issue has placed a premium on the development of new products designed to prevent accidental needle sticks, which spread blood-borne pathogens.
Medical supply manufacturers around the globe are trying to develop new safety and innovative products, including sharps safety medical devices to protect health care workers. The University of Virginia’s International Healthcare Worker Safety Center lists 12 companies offering retractable needles/syringes.
The products involve a variety of technologies, for example, a safety needle device has a needle encapsulation sleeve after it has been used; the sleeve automatically resheathes the needle and locks it so that it cannot be exposed.
Blunt safety devices deploy a two-needle system, one inside the other. The inside needle is hollow and has a flat, blunt end. The outside sharp needle is used to access the vein. The inner needle moves forward and past the sharp needle to insure safety before it is removed from the patient. Such devices are known as first-generation safety products.
The retractable syringe is a unique device requiring no change in the basic procedure of delivery of the medication by health care workers. Once the injection is complete, the needle safely retracts from the patient into the syringe barrel -- thus, there is no risk of accidental needle stick injuries that can transmit HIV, hepatitis, or other infections to health care workers. Retractable syringes are considered second generation safety products.
Needles, Syringes, IV Access Industry Research & Market Reports
-
Aspiration & Biopsy Needles
... 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Biopsy Needles, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.0 Billion by the ... Read More
-
Intravenous (IV) Solutions
... at a CAGR of 7.5% over the analysis period 2024-2030. Parenteral Nutrition, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$15.1 Billion by the end of ... Read More
-
Amniocentesis Needles
... CAGR of 2.1% over the analysis period 2024-2030. 150 mm & Above Needles, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$67.3 Million by the end ... Read More
-
Wearable Injectors
... CAGR of 9.5% over the analysis period 2024-2030. On-Body Injectors, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$14.7 Billion by the end of the analysis ... Read More
-
Infusion Pumps
... CAGR of 4.7% over the analysis period 2024-2030. Volumetric Infusion Pumps, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Endoscopic Ultrasound Needles
... at a CAGR of 2.7% over the analysis period 2024-2030. Aspiration Needles (EUS-FNA), one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$150.5 Million by the end ... Read More
-
Injectable Drugs Delivery
... at a CAGR of 10.1% over the analysis period 2024-2030. Injectable Drugs Delivery Devices, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$1.4 Trillion by the ... Read More
-
Enteral Syringes
... CAGR of 5.6% over the analysis period 2024-2030. Disposable Syringes, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$1.5 Billion by the end of the analysis ... Read More
-
Pipette Tips
... CAGR of 5.1% over the analysis period 2024-2030. Manual Pipette Tips, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$748.2 Million by the end of the ... Read More
-
Huber Needles
... CAGR of 4.8% over the analysis period 2024-2030. Curved Display Needles, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$77.6 Million by the end of the ... Read More
-
Venipuncture Procedure
... CAGR of 4.4% over the analysis period 2024-2030. Median Cubital Vein, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$776.5 Million by the end of the ... Read More
-
Pen Needles
... CAGR of 9.2% over the analysis period 2024-2030. Standard Pen Needles, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
Safety Needles
... CAGR of 6.9% over the analysis period 2024-2030. Active Safety Needles, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$3.2 Billion by the end of the ... Read More
-
Hypodermic Needles
... CAGR of 3.9% over the analysis period 2024-2030. Safety Needles, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More
-
Home Infusion Therapy
... at a CAGR of 6.7% over the analysis period 2024-2030. Infusion Pumps, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$29.4 Billion by the end of ... Read More
-
IV Tubing Sets & Accessories
... Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Primary IV Tubing Sets, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach ... Read More
-
Vaccine Delivery Devices
... at a CAGR of 4.4% over the analysis period 2024-2030. Syringes, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$5.3 Billion by the end of the ... Read More
-
Intravenous Equipment
... CAGR of 3.4% over the analysis period 2024-2030. IV Catheters, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$4.8 Billion by the end of the analysis ... Read More
-
Needle-Free Drug Injection Systems
... 2030, growing at a CAGR of 9.5% over the analysis period 2024-2030. Jet Injectors Technology, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$9.5 Billion by ... Read More
-
Non-PVC IV Bags
... at a CAGR of 7.7% over the analysis period 2024-2030. Single-Chamber IV Bags, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.8 Billion by the end ... Read More
-
Dual Chamber Prefilled Syringes Market Size, Share, Growth,Industry Analysis,Regional Insights and Global Forecast 2024-2032
... from 2024 to 2032. The dual chamber prefilled syringes (DCPS) market is a rapidly growing segment within the global pharmaceutical and biotechnology industries, driven by advancements in drug delivery technologies and increasing demand for efficient, ... Read More
-
IV Bags Material Market Size,Share And Global Forecast 2032
... 2024 to 2032. The IV (intravenous) bags material market plays a pivotal role in the healthcare and pharmaceutical industries, as IV bags are critical components for the administration of fluids, nutrients, medications, and blood products ... Read More
-
Obesity in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2031
... for the obesity market through 2031. GlobalData estimates sales of obesity therapeutics to be approximately $10.5 billion across the 7MM in 2021. By 2031, GlobalData expects the obesity market to grow at a strong compound ... Read More
-
Eylea Global Market Opportunities And Strategies To 2033
... Bayer AG; Biocon Biologics Limited; Samsung Bioepis Co. Ltd.; Amgen Biosimilar Inc. Eylea Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical ... Read More
-
Lyophilized Injectable Drugs Global Market Opportunities And Strategies To 2033
... By Indication: Oncology; Infectious Diseases; Autoimmune Diseases; Metabolic Conditions4) By End-User: Hospitals; Ambulatory Surgery Centers (ASCs); Specialty ClinicsCovering: Novartis AG; Pfizer Inc.; Sanofi SA; Baxter International Inc.; Hikma Pharmaceuticals plc Lyophilized Injectable Drugs Global Market ... Read More
Research Assistance
